PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC
BSE6603.45-93.05 (-1.39 %)
PREV CLOSE ( ) 6696.50
OPEN PRICE ( ) 6723.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 463
TODAY'S LOW / HIGH ( )6582.60 6830.00
52 WK LOW / HIGH ( )2927.8 7499.95
NSE6599.40-99.75 (-1.49 %)
PREV CLOSE( ) 6699.15
OPEN PRICE ( ) 6760.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 14078
TODAY'S LOW / HIGH( ) 6577.25 6829.00
52 WK LOW / HIGH ( )2891.45 7500
Select year
Particulars
Jun 2020
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Operational & Financial Ratios
 
 
 
 
 
   Earnings Per Share (Rs)
153.06  
505.25  
56.57  
47.67  
32.27  
   CEPS(Rs)
170.80  
517.98  
68.09  
62.61  
46.37  
   DPS(Rs)
230.00  
440.00  
15.00  
11.00  
7.50  
   Book NAV/Share(Rs)
544.82  
927.78  
441.72  
399.89  
356.36  
   Tax Rate(%)
28.40  
8.63  
38.29  
31.29  
35.73  
Margin Ratios
 
 
 
 
 
   Core EBITDA Margin(%)
23.18  
16.31  
9.93  
11.22  
8.57  
   EBIT Margin(%)
26.17  
71.26  
21.39  
11.18  
8.56  
   Pre Tax Margin(%)
26.17  
71.26  
21.39  
11.18  
8.56  
   PAT Margin (%)
18.74  
65.11  
13.20  
7.68  
5.50  
   Cash Profit Margin (%)
20.91  
66.75  
15.89  
10.09  
7.90  
Performance Ratios
 
 
 
 
 
   ROA(%)
10.82  
40.93  
6.52  
5.48  
3.92  
   ROE(%)
20.79  
73.79  
13.44  
12.61  
9.35  
   ROCE(%)
29.01  
80.76  
21.79  
18.35  
14.54  
   Asset Turnover(x)
0.58  
0.63  
0.49  
0.71  
0.71  
   Sales/Fixed Asset(x)
7.04  
6.83  
4.24  
4.96  
3.87  
   Working Capital/Sales(x)
1.86  
0.96  
1.35  
2.29  
2.39  
Efficiency Ratios
 
 
 
 
 
   Fixed Capital/Sales(x)
0.14  
0.15  
0.24  
0.20  
0.26  
   Receivable days
21.73  
26.75  
58.92  
41.40  
43.30  
   Inventory Days
33.31  
38.41  
82.51  
58.63  
64.49  
   Payable days
43.33  
49.94  
53.71  
33.69  
25.86  
Valuation Parameters
 
 
 
 
 
   PER(x)
26.57  
6.10  
22.78  
20.93  
24.14  
   PCE(x)
23.81  
5.95  
18.93  
15.93  
16.80  
   Price/Book(x)
7.47  
3.32  
2.92  
2.49  
2.19  
   Yield(%)
5.65  
14.27  
1.16  
1.10  
0.96  
   EV/Net Sales(x)
4.51  
3.01  
2.67  
1.39  
1.18  
   EV/Core EBITDA(x)
15.91  
4.16  
12.06  
9.83  
10.35  
   EV/EBIT(x)
17.23  
4.22  
12.23  
11.95  
13.26  
   EV/CE(x)
2.89  
1.50  
1.23  
1.01  
0.72  
   M Cap / Sales
4.98  
3.97  
3.06  
1.67  
1.38  
Growth Ratio
 
 
 
 
 
   Net Sales Growth(%)
5.26  
84.50  
-29.66  
5.65  
8.30  
   Core EBITDA Growth(%)
-58.79  
504.30  
10.24  
31.13  
34.72  
   EBIT Growth(%)
-61.34  
503.15  
32.14  
38.21  
25.20  
   PAT Growth(%)
-69.71  
793.11  
18.68  
47.74  
23.92  
   EPS Growth(%)
-69.71  
793.11  
18.68  
47.74  
23.92  
Financial Stability Ratios
 
 
 
 
 
   Total Debt/Equity(x)
0.00  
0.00  
0.00  
0.00  
0.00  
   Current Ratio(x)
2.35  
3.45  
2.50  
2.50  
1.76  
   Quick Ratio(x)
2.10  
3.24  
2.05  
1.95  
1.45  
   Interest Cover(x)
NA  
NA  
NA  
NA  
NA  
   Total Debt/Mcap(x)
0.00  
0.00  
0.00  
0.00  
0.00  
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Jerina George, Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075,9768009000, E-mail ID: compliance@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.